Role of supportive care in the future of cell therapies

Cell & Gene Therapy Insights 2026; 12(1), 81–86

DOI: 10.18609/cgti.2026.010

Published: 4 February
Commentary
Liam Tremble, Paula Maguire

Supportive care is typically differentiated from disease modifying therapies as its function is not to cure patients of a disease. Supportive care forms the backbone of the healthcare infrastructure and is of pivotal importance in facilitating the delivery of advanced therapies such as cell therapies, which can present challenging tolerability profiles. For instance, cytokine release syndrome or immune effector cell-associated neurotoxicity syndrome, has led to the discontinuation of a number of cell therapies during development.

}